Center-Authored Papers

Filters: Keyword is Survival Analysis  [Clear All Filters]
A
Anderson JE, Litzow MR, Appelbaum FR, Schoch G, Fisher LD, Buckner CD, Petersen FB, Crawford SW, Press OW, Sanders JE.  1993.  Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(12):2342-50. Abstract
Appelbaum FR.  2008.  Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).. Best practice & research. Clinical haematology. 21(1):85-92. Abstract
Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers MED, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M et al..  2011.  Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.. Blood. 117(24):6714-20. Abstract
B
Baker KS, Armenian S, Bhatia S.  2010.  Long-term consequences of hematopoietic stem cell transplantation: current state of the science.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(1 Suppl):S90-6.
Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM et al..  2001.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(16):3622-34. Abstract
Balducci L, Hardy CL, Lyman GH.  2000.  Hemopoietic reserve in the older cancer patient: clinical and economic considerations.. Cancer control : journal of the Moffitt Cancer Center. 7(6):539-47. Abstract
Baron F, Maris MB, Storer BE, Sandmaier BM, Panse JP, Chauncey TR, Sorror M, Little M-T, Maloney DG, Storb R et al..  2005.  High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 19(5):822-8. Abstract
Bateganya MH, Stanaway J, Brentlinger PE, Magaret AS, Wald A, Orem J, Casper C.  2011.  Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment.. Journal of acquired immune deficiency syndromes (1999). 56(4):312-9. Abstract
Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Ceballos RM, Titus-Ernstoff L, Egan KM, Holmes MD.  2010.  Social networks and survival after breast cancer diagnosis.. Journal of cancer survivorship : research and practice. 4(4):372-80. Abstract
Bensinger WI, Jagannath S, Vescio R, Camacho E, Wolf J, Irwin D, Capo G, McKinley M, Potts P, Vesole DH et al..  2010.  Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma.. British journal of haematology. 148(4):562-8. Abstract
Blumenthal DT, Rankin C, Eyre HJ, Livingston RB, Spence AM, Stelzer KJ, Rushing EJ, Berger MS, Rivkin SE, Cohn AL et al..  2008.  External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial.. Cancer. 113(3):559-65. Abstract
Breslow NE, Lange JM, Friedman DL, Green DM, Hawkins MM, Murphy MFG, Neglia JP, Olsen JH, Peterson SM, Stiller CA et al..  2010.  Secondary malignant neoplasms after Wilms tumor: an international collaborative study.. International journal of cancer. Journal international du cancer. 127(3):657-66. Abstract
Brobeil A, Berman C, Cruse CW, De Conti R, Cantor A, Lyman GH, Joseph E, Rapaport D, Wells K, Reintgen DS.  1998.  Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma.. Annals of surgical oncology. 5(4):376-83. Abstract
Brown ER, Otieno P, Mbori-Ngacha DA, Farquhar C, Obimbo EM, Nduati R, Overbaugh J, John-Stewart GC.  2009.  Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women.. The Journal of infectious diseases. 199(9):1292-300. Abstract
Bruno B, Rotta M, Patriarca F, Mattei D, Allione B, Carnevale-Schianca F, Sorasio R, Rambaldi A, Casini M, Parma M et al..  2009.  Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo.. Blood. 113(14):3375-82. Abstract
Budde MW, Roth MB.  2010.  Hydrogen sulfide increases hypoxia-inducible factor-1 activity independently of von Hippel-Lindau tumor suppressor-1 in C. elegans.. Molecular biology of the cell. 21(1):212-7. Abstract
C
Carlson JJ, Reyes C, Oestreicher N, Lubeck D, Ramsey SD, Veenstra DL.  2008.  Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC).. Lung cancer (Amsterdam, Netherlands). 61(3):405-15. Abstract
Chamberlain MC, Raizer J.  2009.  Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia.. Journal of neuro-oncology. 93(2):229-32. Abstract
Chamberlain MC, Glantz MJ.  2008.  CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma.. Journal of neuro-oncology. 89(2):231-8. Abstract
Chang AE, Chai X, Pollack SM, Loggers E, Rodler E, Dillon J, Parvathaneni U, Moe KS, Futran N, Jones RL.  2014.  Analysis of clinical prognostic factors for adult patients with head and neck sarcomas.. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 151(6):976-83. Abstract
Chansky K, Sculier J-P, Crowley J, Giroux D, Van Meerbeeck J, Goldstraw P.  2009.  The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 4(7):792-801. Abstract
Chen L, Hsu L, Malone KE.  2009.  A frailty-model-based approach to estimating the age-dependent penetrance function of candidate genes using population-based case-control study designs: an application to data on the BRCA1 gene.. Biometrics. 65(4):1105-14. Abstract
Chen Y, Chen C.  2008.  DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.. Head & neck. 30(10):1361-83. Abstract
Chilongozi D, Wang L, Brown L, Taha T, Valentine M, Emel L, Sinkala M, Kafulafula G, Noor RA, Read JS et al..  2008.  Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania.. The Pediatric infectious disease journal. 27(9):808-14. Abstract
Cosler LE, Eldar-Lissai A, Culakova E, Kuderer NM, Dale D, Crawford J, Lyman GH.  2007.  Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective.. PharmacoEconomics. 25(4):343-51. Abstract